Site notifications

Sub menu

 

 

DERMESTRIL 50 estradiol 50 micrograms/24 hours transdermal patches (Italy)

Section 19A approved medicine
DERMESTRIL 50 estradiol 50 micrograms/24 hours transdermal patches (Italy)
Section 19A approval holder
Phero Pharma Pty Ltd ABN 96 673 730 231​
Phone
02 9420 9199
Approved until
Status
Current
Medicines in short supply/unavailable
ESTRADOT 50 estradiol 50 microgram transdermal drug delivery system sachet - ARTG 338058
ESTRADERM MX 50 estradiol 50 microgram/24 hours transdermal drug delivery system sachet - ARTG 56658
Indication(s)

Short term treatment of symptoms of estrogen deficiency due to the menopause, whether natural or surgically induced.

In women with an intact uterus, estrogen should always be opposed by progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals.

Combination HRT should not be used in hysterectomised women because it is not needed in these women and it may increase the risk of breast cancer.

Related medicines shortage notifications
https://apps.tga.gov.au/Prod/msi/Search/Tradename//338058
Images
Picture of DERMESTRIL 50 estradiol 50 micrograms/24 hours patches - carton